English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Results: 52 infants had SBS during the study period, a cumulative incidence of 14 per 1000 NICU admissions. 30 (58%) were treated with CEA for suspected SBBO. NEC represented the most common aetiology for SBS 18/52. Among the infants who received CEA, the most consistent feature identified preceding treatment was poor weight gain (93%) followed by bowel dilata-tion on abdominal radiograph (80%). There was a significant improvement in the trend of stoma outputs and cholestasis among the infants who received 6 weeks of CEA. No difference was however found with regards to change in acid base and electrolytes status, or nutritional parameters over time between the two groups (p>0.05).

journal of surgery

Cycled Enteral Antibiotics in Suspected Small Bowel Bacterial Overgrowth Complicating Short Bowel Syndrome - Experience from a Tertiary Neonatal Centre of Canada